Additionally, incretin use with basal insulin may delay the use of bolus (mealtime) insulin with reduced risk of hypoglycemia
Pretreatment with GLP-1 reduced AMPK phosphorylation in MG-treated INS-1 and MIN6 cells (Fig
Across multiple STEP trials, the enrollment criteria required a BMI of 30 or higher, or 27 or higher with at least one weight-related comorbidity (excluding type 2 diabetes, which was studied separately)
Within three to four years, the oral small-molecule sub-class is likely to have at least one or two more approved members, and price competition will start to put pressure on the injectables in cash-pay and lower-income markets
In addition, P-gp- and BCRP-mediated efflux was inhibited by tirzepatide
dosage and protocol may vary